Search is Powered by Google
Multiple Sclerosis News

New Quality Assurance On The Way For Health And Social Care Information, UK

Main Category: Multiple Sclerosis
Article Date: 01 Sep 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

The MS Society has been chosen by the Department of Health from over 120 applications to participate in the testing phase of a new scheme to ensure good quality information across the health and social care sector.

The information accreditation scheme will combat substantial variation in the quality of health and social care information available and will provide a way for the public and professionals to know that the information they are using is reliable.

It will also support information producers in raising general standards and will be focused at the organisation level - accrediting the source of information rather than the information itself.

The MS Society - the largest organisation supoprting people with multiple sclerosis (MS) in the UK - is testing the scheme alongside others from the commercial, public and voluntary sectors. Subject to achieving certification through this testing phase, the charity will become one of the first scheme members when it launches in 2009.

David Potter, Information Services Manager, said: "The MS Society prides itself on evidence-based information and it is essential that the materials accessed by people affected by MS are authoritative and accurate.

"We are delighted to be chosen by the Department of Health to be part of the new Quality Assurance pilot scheme and look forward to helping to make sure information on health and social care is of the best possible quality."

Ann Keen MP, the parliamentary under-secretary for health services, said, "There is so much information out there that it's hard for people - both the public and professionals - to know what can be relied upon. A scheme with a recognisable quality mark, will assure them that information is from a dependable source.

"Over 120 applications were received by the Department of Health and the MS Society is one of just 40 organisations to have successfully made it through the application process. The work of these test sites will be invaluable in providing knowledge and insight for organisations who are considering joining the scheme in the future."

As part of the testing phase the MS Society will be involved in:

- testing the scheme Standard
- sharing experiences in order to support the development of case studies
- helping to develop the visual identity of the quality mark.

MS Society




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
New Data Show Patients Using AVONEX Reported Less Sick Leave And Short-Term Disability Costs
04 Jun 2008
Results from an analysis assessing the differences in health benefits costs (HBCs) and lost time among employees suffering from multiple sclerosis (MS) being treated with injectable disease modifying therapies (DMTs) were...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

An MS Drug Back on the Market image An MS Drug Back on the Market

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in place because of a small risk in developing a serious brain infection. Should you consider taking this drug...

View more videos...